28th February 2025

A 65-year-old man has a new diagnosis of localised prostate cancer. He is

A 65-year-old man has a new diagnosis of localised prostate cancer. He is independently mobile and independent with activities of daily living. His past medical history includes hypertension, hypercholesterolemia, and type two diabetes. Medications include metformin, ramipril and atorvastatin.

His urologist explains his possible treatment options and he opts for active surveillance. Which of the following options most accurately describes NICE guidance for active surveillance in year two onwards in localised prostate cancer?

Select the SINGLE most appropriate option from the list below. Select ONE option only.